HealthWarehouse.com reported net sales of $15 million for Q1 2025, nearly tripling from $5.1 million in the same period last year.

The increase was driven by a 616% rise in its business-to-business (B2B) operations, where the company fulfills prescriptions — primarily GLP-1 medications — for telehealth providers and digital clinics. HealthWarehouse.com is an online pharmacy that serves more than 450,000 customers nationwide.

HealthWarehouse.com Q1 sales growth

Prescription sales reached $14.4 million, up 226% year over year. Most of that growth came from B2B partners relying on HealthWarehouse.com for cold-chain logistics and high-volume order processing. CEO Joseph Peters said the company’s infrastructure is proving scalable and dependable, allowing it to meet rising demand from health care partners.

While B2B sales surged, direct-to-consumer prescriptions declined 26% following reduced ad spending, and over-the-counter product sales dropped 12%.

Gross profit rose 54% to $4.5 million, though the gross margin fell to 30% from 58% due to lower-margin B2B products. Operating expenses increased 37%, driven by shipping and staffing costs. The company reported net income of $178,000 — its second straight quarterly profit — compared to a loss of $252,000 a year ago. Adjusted EBITDA rose to $521,000 from $90,000.

HealthWarehouse.com continues to invest in technology and operations to support growth in both its consumer and partner businesses.

Sign up

Sign up for a complimentary subscription to Digital Commerce 360 B2B News. It covers technology and business trends in the growing B2B ecommerce industry. Contact Mark Brohan, senior vice president of B2B and Market Research, at [email protected]. Follow him on Twitter @markbrohan. Follow us on LinkedIn, X (formerly Twitter), Facebook and YouTube.